3175 results for «401»

Filter By

3175 results

Procedural imaging for tricuspid valve interventions

15 Feb 2026 – From PCR Tokyo Valves 2026

Dedicated to procedural imaging for tricuspid valve interventions, this session elucidates anatomical and pathophysiological features critical for successful transcatheter procedures. It emphasizes technical aspects of TEE and ICE imaging, including 3D multiplanar reconstruction, and offers case-based learning to refine imaging skills and optimize procedural outcomes.

Procedural imaging for tricuspid valve interventions

Miscellaneous complications: my worst nightmare

15 Feb 2026 – From PCR Tokyo Valves 2026

Explore the prevention and management of complications arising from transcatheter interventions in structural heart disease through challenging case analyses. This session presents real-world scenarios addressing complications encountered during TAVI, mitral, and tricuspid procedures, highlighting strategies to anticipate and manage these critical events effectively.

Miscellaneous complications: my worst nightmare

Transcatheter valve-in-valve intervention: LIVE Educational Case from The Prince Charles Hospital, Metro North Health - Brisbane, Australia

14 Feb 2026 – From PCR Tokyo Valves 2026

Review a live educational case from The Prince Charles Hospital focused on transcatheter valve-in-valve intervention, highlighting anatomical challenges, critical CT imaging roles, and meticulous planning to prevent complications and ensure favorable outcomes.

Transcatheter valve-in-valve intervention: LIVE Educational Case from The Prince Charles Hospital, Metro North Health - Brisbane, Australia

Late-breaking trials of PCR Tokyo Valves 2026

14 Feb 2026 – From PCR Tokyo Valves 2026

This session presents pivotal late-breaking trials from PCR Tokyo Valves 2026, offering one-year outcomes and real-world experiences in transcatheter valve therapies. Highlights include the AltaValve early feasibility study on atrial fixation TMVR, invasive registry insights on prosthesis-patient mismatch post-TAVR, and registry data on tricuspid and mitral...

Late-breaking trials of PCR Tokyo Valves 2026

PCR Tokyo Valves 2026 Welcome Ceremony

14 Feb 2026 – From PCR Tokyo Valves 2026

The Welcome Ceremony marks the commencement of the conference, setting the stage for an engaging and informative program dedicated to advances in cardiology and interventional techniques. It provides attendees with an overview of the event's objectives and highlights the collaborative spirit of the cardiology community.

Welcome Ceremony

Tricuspid: LIVE Educational Case from The Prince Charles Hospital, Metro North Health - Brisbane, Australia

14 Feb 2026 – From PCR Tokyo Valves 2026

This educational session from The Prince Charles Hospital in Brisbane offers a comprehensive live case demonstration of tricuspid TEER. It covers patient selection, procedural planning with multimodality imaging, step-by-step procedural strategies, and post-procedural assessment emphasizing echocardiographic evaluation and short-term outcomes.

Tricuspid: LIVE Educational Case from The Prince Charles Hospital, Metro North Health - Brisbane, Australia

Hot topics and evidence on structural interventions in 2025 and 2026

14 Feb 2026 – From PCR Tokyo Valves 2026

Delve into the emerging clinical evidence and key hot topics shaping transcatheter interventions for aortic, mitral, and tricuspid valve diseases anticipated to influence clinical practice in 2025 and 2026. This session reviews stroke prevention, valve interventions across the three valves, and integrates recent and upcoming data...

Hot topics and evidence on structural interventions in 2025 and 2026

Prevention and management of TAVI complications

14 Feb 2026 – From PCR Tokyo Valves 2026

This session addresses the prevention and management of major complications associated with transcatheter aortic valve implantation (TAVI). Attendees will gain a detailed understanding of mechanisms behind cerebral infarction, haemolysis, valve infolding, pacemaker implantation, and valve migration, along with expert strategies for recognition, decision-making, and bailout techniques...

Prevention and management of TAVI complications

Guidelines update

15 Feb 2026 – From PCR Tokyo Valves 2026

This session reviews the latest updates in the ESC/EACTS guidelines for structural heart disease, emphasizing their clinical implications and future trends. Participants will gain understanding of changes in aortic, mitral, and tricuspid valve recommendations, including new age cutoffs, asymptomatic disease management, and the evolving role of...

Guidelines update

Mitral TEER: LIVE Educational Case from Nagoya Heart Center - Nagoya, Japan

15 Feb 2026 – From PCR Tokyo Valves 2026

This session from Nagoya Heart Center provides an in-depth exploration of contemporary mitral Transcatheter Edge-to-Edge Repair (TEER), emphasizing the pivotal role of advanced imaging in transcatheter mitral interventions. It also discusses the available transcatheter treatment options tailored for complex mitral valve disease, featuring live case demonstrations,...

Mitral TEER: LIVE Educational Case from Nagoya Heart Center - Nagoya, Japan

Future devices and techniques for structural heart disease

15 Feb 2026 – From PCR Tokyo Valves 2026

This session surveys the future landscape of structural heart disease treatment, addressing current limitations in transcatheter valve technologies and presenting emerging devices and techniques for aortic, mitral, and tricuspid valves. Attendees will gain insights into innovations poised to transform therapeutic options for structural heart disease.

Future devices and techniques for structural heart disease

Percutaneous thrombectomy of a large thrombus in transit

15 Jun 2022

View the case of a 60-year-old male patient who was diagnosed with pulmonary embolism and a large TIT, and see how he was treated by percutaneous thrombectomy.

Percutaneous thrombectomy of a large thrombus in transit

Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials

14 Nov 2021

Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.

Vijay Kunadian

Author

Vijay Kunadian
Best of #AHA21 Scientific sessions

3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

22 Mar 2022

Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Author

Ali Nazmi Calik
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease

02 Sep 2025

Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTION STEMI - Immediate vs staged complete revascularisation during index admission in patients with STEMI & MVD
Didn’t find what you were looking for?